{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T21:26:03Z","timestamp":1785101163496,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Sex Behav"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10508-024-02862-0","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T20:19:53Z","timestamp":1716409193000},"page":"2445-2452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Factors Associated with PrEP Persistence and Loss of Follow-Up: A 5-Year Historic Cohort"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3733-4085","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Le Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Florent","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathie","family":"Faussat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Aumond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Stefic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Grammatico-Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"issue":"3","key":"2862_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-3018(20)30271-X","volume":"8","author":"J Ambrosioni","year":"2021","unstructured":"Ambrosioni, J., Petit, E., Liegeon, G., Laguno, M., & Mir\u00f3, J. M. (2021). Primary HIV-1 infection in users of pre-exposure prophylaxis. The Lancet. HIV, 8(3), 166\u2013174.","journal-title":"The Lancet. HIV"},{"key":"2862_CR2","unstructured":"Anguis, M., Bergeat, M., Pisarik, J., Vergier, N., & Chaput, H. (2021). Quelle d\u00e9mographie r\u00e9cente et \u00e0 venir pour les professions m\u00e9dicales et pharmaceutique? Constat et projections d\u00e9mographiques (Les dossiers de la DREES 76; p. 74). DREES."},{"issue":"2","key":"2862_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S2352-3018(19)30341-8","volume":"7","author":"G Antoni","year":"2020","unstructured":"Antoni, G., Tremblay, C., Delaugerre, C., Charreau, I., Cua, E., Rojas Castro, D., Raffi, F., Chas, J., Huleux, T., Spire, B., Capitant, C., Cotte, L., Meyer, L., Molina, J.-M., ANRS IPERGAY study group. (2020). On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: A post-hoc analysis of the ANRS IPERGAY Trial. The Lancet. HIV, 7(2), 113\u2013120.","journal-title":"The Lancet. HIV"},{"key":"2862_CR4","unstructured":"Billioti de Gage, S., Le-Tri, T., & Dray-Spira, R. (2020). Suivi de l\u2019utilisation de Truvada\u00ae ou g\u00e9n\u00e9riques pour une prophylaxie pr\u00e9-exposition (PrEP) au VIH \u00e0 partir des donn\u00e9es du Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS) (EPI-PHARE; Epid\u00e9miologie des produits de sant\u00e9, p. 45). GIS ANSM-CNAM."},{"issue":"8","key":"2862_CR5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s10461-020-02789-2","volume":"24","author":"A Braksmajer","year":"2020","unstructured":"Braksmajer, A., Walters, S. M., Crean, H. F., Stephenson, R., & McMahon, J. M. (2020). Pre-exposure prophylaxis use among men who have sex with men experiencing partner violence. AIDS and Behavior, 24(8), 2299\u20132306. https:\/\/doi.org\/10.1007\/s10461-020-02789-2","journal-title":"AIDS and Behavior"},{"key":"2862_CR6","unstructured":"Cazein, F., Pillonel, J., Sommen, C., Bruyand, M., Lydi\u00e9, N., Che, D., Coignard, B., & Lot, F. (2019). Bulletin de sant\u00e9 publique VIH\/sida. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/bulletin-national\/bulletin-de-sante-publique-vih-sida.-octobre-2019"},{"key":"2862_CR7","unstructured":"Cessa, D. (2021). Facteurs de risques addictologiques dans le cadre du Chemsex\u202f: R\u00e9sultats de l\u2019\u00e9tude nationale en ligne Sea, Sex and Chems [Th\u00e8se d\u2019exercice]. Universit\u00e9 d\u2019Aix Marseille."},{"issue":"22","key":"2862_CR8","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou, R., Evans, C., Hoverman, A., Sun, C., Dana, T., Bougatsos, C., Grusing, S., & Korthuis, P. T. (2019). Preexposure prophylaxis for the prevention of HIV infection: Evidence report and systematic review for the US Preventive Services Task Force. Journal of the American Medical\nAssociation, 321(22), 2214\u20132230.","journal-title":"JAMA"},{"key":"2862_CR9","unstructured":"Colin, M. (2020). Acceptabilit\u00e9 Du Renouvellement Du Traitement Pr\u00e9-Exposition Du VIH Ou PrEP En M\u00e9decine G\u00e9n\u00e9rale\u202f: Enqu\u00eate Aupr\u00e8s Des Patients et Des M\u00e9decins G\u00e9n\u00e9ralistes de La R\u00e9gion Centre-Val de Loire [Th\u00e8se d\u2019exercice]. Universit\u00e9 de Tours."},{"key":"2862_CR10","unstructured":"Duhamel, G., & Morelle, A. (2017). Evaluation de la recommandation temporaire d\u2019utilisation de TRUVADA \u00ae dans la prophylaxie pr\u00e9-exposition de l\u2019infection par le VIH\u202f: Un enseignement pour la sant\u00e9 publique."},{"issue":"HS1","key":"2862_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3917\/spub.220.0002b","volume":"34","author":"C Faussat","year":"2022","unstructured":"Faussat, C., Bonnin, A., Hilt, D., Rivi\u00e8re-da Silva, F., Michels, D., Gras, G., Aumond, C., & Grammatico-Guillon, L. (2022). e-PrEP: Int\u00e9r\u00eats et limites d\u2019un dispositif de t\u00e9l\u00e9consultations pour la prophylaxie pr\u00e9-exposition (PrEP). Sant\u00e9 Publique, 34(HS1), 2\u20132. https:\/\/doi.org\/10.3917\/spub.220.0002b","journal-title":"Sant\u00e9 Publique"},{"issue":"2","key":"2862_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1524838012470034","volume":"14","author":"C Finneran","year":"2013","unstructured":"Finneran, C., & Stephenson, R. (2013). Intimate partner violence among men who have sex with men: A systematic review. Trauma, Violence & Abuse, 14(2), 168\u2013185. https:\/\/doi.org\/10.1177\/1524838012470034","journal-title":"Trauma, Violence & Abuse"},{"key":"2862_CR13","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.drugalcdep.2021.108875","volume":"226","author":"JL Flores Anato","year":"2021","unstructured":"Flores Anato, J. L., Panagiotoglou, D., Greenwald, Z. R., Trottier, C., Vaziri, M., Thomas, R., & Maheu-Giroux, M. (2021). Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montr\u00e9al, Canada (2013\u20132020). Drug and Alcohol Dependence, 226, 108875.","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"2862_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40265-019-01108-x","volume":"79","author":"KM Gibas","year":"2019","unstructured":"Gibas, K. M., van den Berg, P., Powell, V. E., & Krakower, D. S. (2019). Drug resistance during HIV pre-exposure prophylaxis. Drugs, 79(6), 609\u2013619.","journal-title":"Drugs"},{"key":"2862_CR15","unstructured":"Global Advocacy for HIV Prevention. (2022). Data PrEP watch. https:\/\/data.prepwatch.org\/"},{"issue":"1","key":"2862_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/COH.0000000000000220","volume":"11","author":"JE Haberer","year":"2016","unstructured":"Haberer, J. E. (2016). Current concepts for PrEP adherence in the PrEP revolution: From clinical trials to routine practice. Current Opinion in HIV and AIDS, 11(1), 10\u201317.","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"4","key":"2862_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2352-3018(19)30344-3","volume":"7","author":"C Hendrickson","year":"2020","unstructured":"Hendrickson, C., Long, L., van de Vijver, D., Boucher, C., O\u2019Bra, H., Claassen, C. W., Njelesani, M., Moyo, C., Mumba, D. B., Subedar, H., Mulenga, L., Rosen, S., & Nichols, B. E. (2020). Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settings. The Lancet HIV, 7(4), 294\u2013300.","journal-title":"The Lancet. HIV"},{"issue":"6","key":"2862_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1071\/SH18125","volume":"15","author":"I Hodges-Mameletzis","year":"2018","unstructured":"Hodges-Mameletzis, I., Dalal, S., Msimanga-Radebe, B., Rodolph, M., & Baggaley, R. (2018). Going global: The adoption of the World Health Organization\u2019s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sexual Health, 15(6), 489\u2013500.","journal-title":"Sexual Health"},{"key":"2862_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00799","author":"X Huang","year":"2018","unstructured":"Huang, X., Hou, J., Song, A., Liu, X., Yang, X., Xu, J., Zhang, J., Hu, Q., Chen, H., Chen, Y., Meyers, K., & Wu, H. (2018). Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: A systematic review and meta-analysis. Frontiers in Pharmacology, 9. https:\/\/doi.org\/10.3389\/fphar.2018.00799","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"2862_CR20","doi-asserted-by":"publisher","first-page":"e87674","DOI":"10.1371\/journal.pone.0087674","volume":"9","author":"J Jiang","year":"2014","unstructured":"Jiang, J., Yang, X., Ye, L., Zhou, B., Ning, C., Huang, J., Liang, B., Zhong, X., Huang, A., Tao, R., Cao, C., Chen, H., & Liang, H. (2014). Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: A meta-analysis of randomized controlled trials. PLoS ONE, 9(2), e87674.","journal-title":"PLoS ONE"},{"key":"2862_CR21","unstructured":"LOI n\u00b0 2016\u201341 du 26 janvier 2016 de modernisation de notre syst\u00e8me de sant\u00e9 (1), 2016\u201341 (2016)."},{"issue":"4","key":"2862_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/QAI.0000000000001534","volume":"76","author":"M Markowitz","year":"2017","unstructured":"Markowitz, M., Grossman, H., Anderson, P. L., Grant, R., Gandhi, M., Horng, H., & Mohri, H. (2017). Newly acquired infection with multidrug-resistant HIV-1 in a patient adherent to preexposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999), 76(4), 104\u2013106.","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"key":"2862_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.drugpo.2018.11.014","volume":"63","author":"S Maxwell","year":"2019","unstructured":"Maxwell, S., Shahmanesh, M., & Gafos, M. (2019). Chemsex behaviours among men who have sex with men: A systematic review of the literature. International Journal on Drug Policy, 63, 74\u201389.","journal-title":"The International Journal on Drug Policy"},{"issue":"23","key":"2862_CR24","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"J-M Molina","year":"2015","unstructured":"Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., Raffi, F., Pintado, C., Chidiac, C., Chas, J., Charbonneau, P., Delaugerre, C., Suzan-Monti, M., Loze, B., Fonsart, J., et al. (2015). On-demand preexposure prophylaxis in men high risk\nfor HIV-1 infection. The New England Journal of Medicine, 373(23), 2237\u20132246.","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"2862_CR25","doi-asserted-by":"publisher","first-page":"0157742","DOI":"10.1371\/journal.pone.0157742","volume":"11","author":"MC Montgomery","year":"2016","unstructured":"Montgomery, M. C., Oldenburg, C. E., Nunn, A. S., Mena, L., Anderson, P., Liegler, T., Mayer, K. H., Patel, R., Almonte, A., & Chan, P. A. (2016). Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting. PLoS ONE, 11(6), 0157742.","journal-title":"PLoS ONE"},{"issue":"15","key":"2862_CR26","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000001939","volume":"32","author":"M Noret","year":"2018","unstructured":"Noret, M., Balavoine, S., Pintado, C., Siguier, M., Brun, A., Bauer, R., Loze, B., Leplatois, A., Aslan, A., Moudachirou, K., Delaugerre, C., Rozenbaum, W., & Molina, J.-M. (2018). Daily or on-demand oral tenofovir disoproxil fumarate\/emtricitabine for HIV pre-exposure prophylaxis: Experience from a hospital-based clinic in France. AIDS, 32(15), 2161\u20132169.","journal-title":"AIDS"},{"issue":"1","key":"2862_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/0956462416666753","volume":"28","author":"Z Ottaway","year":"2017","unstructured":"Ottaway, Z., Finnerty, F., Amlani, A., Pinto-Sander, N., Szanyi, J., & Richardson, D. (2017). Men who have sex with men diagnosed with a sexually transmitted infection are significantly more likely to engage in sexualised drug use. International Journal of STD & AIDS, 28(1), 91\u201393.","journal-title":"International Journal of STD & AIDS"},{"issue":"Supplement 1","key":"2862_CR28","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/QAD.0000000000003103","volume":"36","author":"P Patel","year":"2022","unstructured":"Patel, P., Sato, K., Bhandari, N., Kanagasabai, U., Schelar, E., Cooney, C., Eakle, R., Klucking, S., Toiv, N., & Saul, J. (2022). From policy to practice: Uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President\u2019s Emergency Plan for AIDS Relief-supported countries, 2017\u20132020. AIDS, 36(Supplement 1), S15.","journal-title":"AIDS"},{"issue":"11","key":"2862_CR29","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","volume":"22","author":"RM Pinto","year":"2018","unstructured":"Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681\u20133691.","journal-title":"AIDS and Behavior"},{"key":"2862_CR30","unstructured":"Prophylaxie (PrEP) du VIH par t\u00e9nofovir disoproxil \/ emtricitabine dans le cadre de l\u2019urgence sanitaire. (2021). [R\u00e9ponses rapides dans le cadre de la COVID-19]. HAS."},{"key":"2862_CR31","unstructured":"R\u00e9sultats de l\u2019appel \u00e0 projets et r\u00e9sum\u00e9s des projets retenus. (2017). Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9."},{"issue":"7","key":"2862_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/OLQ.0000000000001181","volume":"47","author":"JM Ricks","year":"2020","unstructured":"Ricks, J. M. (2020). Trauma-informed human immunodeficiency virus prevention for black men who have sex with men: A critical need [Commentary]. Sexually Transmitted Diseases, 47(7), 447\u2013449. https:\/\/doi.org\/10.1097\/OLQ.0000000000001181","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"2862_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/QAI.0000000000001781","volume":"79","author":"P Roux","year":"2018","unstructured":"Roux, P., Fressard, L., Suzan-Monti, M., Chas, J., Sagaon-Teyssier, L., Capitant, C., Meyer, L., Tremblay, C., Rojas-Castro, D., Pialoux, G., Molina, J.-M., & Spire, B. (2018). Is on-demand HIV pre-exposure prophylaxis a suitable tool for men who have sex with men who practice chemsex? Results from a substudy of the ANRS-IPERGAY Trial. Journal of Acquired Immune Deficiency Syndromes, 79(2), 69\u201375.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"2862_CR34","unstructured":"Sant\u00e9 publique France. (2023, Novembre). Bulletin de sant\u00e9 publique\u2014Surveillance et pr\u00e9vention des infections \u00e0 VIH et des infections sexuellement transmissibles bact\u00e9riennes. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/bulletin-national\/bulletin-de-sante-publique-vih-ist.-novembre-2023"},{"issue":"5","key":"2862_CR35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/QAI.0000000000002712","volume":"87","author":"CM Schumacher","year":"2021","unstructured":"Schumacher, C. M., Tao, X., Chandran, A., Fields, E., Price, A., Greenbaum, A., Jennings, J. M., Collaborative, the I. P. (2021). Reaching those most at risk for acquisition: Evaluating racial\/ethnic\ndisparities in the preexposure prophylaxis care continuum in Baltimore City, Maryland. JAIDS Journal of Acquired Immune Deficiency Syndromes, 87(5), 1145\u20131153.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"2862_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drugpo.2019.03.021","volume":"68","author":"J Sewell","year":"2019","unstructured":"Sewell, J., Cambiano, V., Speakman, A., Lampe, F. C., Phillips, A., Stuart, D., Gilson, R., Asboe, D., Nwokolo, N., Clarke, A., & Rodger, A. J. (2019). Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 Study. International Journal of Drug Policy, 68, 54\u201361.","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"2862_CR37","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1093\/jac\/dkz220","volume":"74","author":"M Siguier","year":"2019","unstructured":"Siguier, M., Mera, R., Pialoux, G., Ohayon, M., Cotte, L., Valin, N., Ghosn, J., Cua, E., Pintado, C., Chas, J., Barriere, G., Durand, F., & Molina, J. M. (2019). First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate\/emtricitabine. Journal of Antimicrobial Chemotherapy, 74(9), 2752\u20132758.","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"2862_CR38","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1093\/jac\/dkab263","volume":"76","author":"M-F Tassi","year":"2021","unstructured":"Tassi, M.-F., Laurent, E., Gras, G., Lot, F., Barin, F., de Gage, S. B., Stefic, K., & Grammatico-Guillon, L. (2021). PrEP monitoring and HIV incidence after PrEP initiation in France: 2016\u201318 nationwide cohort study. Journal of Antimicrobial Chemotherapy, 76(11), 3002\u20133008.","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"21","key":"2862_CR39","doi-asserted-by":"publisher","first-page":"14295","DOI":"10.3390\/ijerph192114295","volume":"19","author":"B Thomas","year":"2022","unstructured":"Thomas, B., Piron, P., de La Rochebrochard, E., Segouin, C., & Troude, P. (2022). Is HIV pre-exposure prophylaxis among men who have sex with men effective in a real-world setting? Experience with one-on-one counseling and support in a sexual health center in Paris, 2018\u20132020. International Journal of Environmental Research and Public Health, 19(21), 14295.","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"2862_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/hiv.12989","volume":"22","author":"KW To","year":"2021","unstructured":"To, K. W., & Lee, S. S. (2021). A review of reported cases of HIV pre-exposure prophylaxis failure with resultant breakthrough HIV infections. HIV Medicine, 22(2), 75\u201382.","journal-title":"HIV Medicine"},{"issue":"5","key":"2862_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.whi.2021.05.003","volume":"31","author":"TC Willie","year":"2021","unstructured":"Willie, T. C., Alexander, K. A., Kershaw, T., Campbell, J. C., & Stockman, J. K. (2021). No longer the exception, but the standard: Integrating trauma-informed policy and pre-exposure prophylaxis implementation for women. Women\u2019s Health Issues, 31(5), 415\u2013419. https:\/\/doi.org\/10.1016\/j.whi.2021.05.003","journal-title":"Women\u2019s Health Issues : Official Publication of the Jacobs Institute of Women\u2019s Health"},{"issue":"5","key":"2862_CR42","doi-asserted-by":"publisher","first-page":"25733","DOI":"10.1002\/jia2.25733","volume":"24","author":"HJ Wu","year":"2021","unstructured":"Wu, H. J., Ku, S. W., Chang, H. H., Li, C. W., Ko, N. Y., & Strong, C. (2021). Imperfect adherence in real life: A prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men\u2014A prospective cohort study in Taiwan. Journal of the International AIDS Society, 24(5), e25733. https:\/\/doi.org\/10.1002\/jia2.25733","journal-title":"Journal of the International AIDS Society"}],"container-title":["Archives of Sexual Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-024-02862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10508-024-02862-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-024-02862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:16:42Z","timestamp":1719901002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10508-024-02862-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2862"],"URL":"https:\/\/doi.org\/10.1007\/s10508-024-02862-0","relation":{},"ISSN":["0004-0002","1573-2800"],"issn-type":[{"value":"0004-0002","type":"print"},{"value":"1573-2800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered in the internal register of the spon-sor establishment under no. 2021_056, in compliance with French national data protection authority (Commission for Data Protection and Liberties\u2014Commission Nationale Informatique et Libert\u00e9s, CNIL) requirements. The consultants at the CeGIDD 37 received collective information on the processing of personal data and were informed that they could, at any time, object to the use of their data. The study received ethical approval under number 2024_033 from the Clinical Research Ethics Group of the University Hospital of Tours (CHRU).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}